Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
Phosphodiesterases in neurodegenerative disorders.
Vitamin D in Systemic and Organ-Specific Autoimmune Diseases.
Kynurenines in the CNS: recent advances and new questions.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Current status of chemokines in the adult CNS.
[Neuro-ophthalmology: the eye as a window to the brain].
Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica.
Alexithymia in Neurological Disease: A Review.
The role of epidemiology in MS research: Past successes, current challenges and future potential.
Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates.
Ischemic Preconditioning in White Matter: Magnitude and Mechanism.
Genetic predictors of relapse rate in pediatric MS.
Clinical data and regulatory issues of biosimilar products.
Magnetic Resonance Spectroscopy: A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
Natalizumab Continued Past 24 Months Safely in MS
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis.
Symptomatic Thoracic Spinal Cord Herniation: Case Series and Technical Report.
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
Pages
« first
‹ previous
…
357
358
359
360
361
362
363
364
365
…
next ›
last »